Bonesupport is a Swedish orthobiologics company commercializing CERAMENT, an injectable ceramic bone-graft substitute. The products fill bone voids and can deliver local antibiotics, supporting reconstruction after trauma, infection or revision surgery. Surgeons in Europe and the U.S. are the primary customers; the platform’s dual bone-healing and infection-management profile is its main clinical differentiator.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q4 2024 | 257 | — | 53.9 | — |
| Q1 2025 | 283.5 | — | 10.4 | — |
| Q2 2025 | 284.4 | — | 53.1 | — |
| Q4 2025 | 312.6 | 21.6% | 44.1 | -18.1% |
| Q1 2026 | 324 | 14.3% | 53.4 | 411.9% |
| Q2 2026 | 355.7 | 25.1% | 81.9 | 54.3% |
All markets — KeepWinning global stock screener
Other companies on Stockholm: Altra Fastigheter AB (publ) (ALTRA), Nolato AB (publ) (NOLA B), Avarda Bank AB (publ) (AVARDA), FastPartner AB (publ) (FPAR D), Ambea AB (publ) (AMBEA), Alimak Group AB (publ) (ALIG)